EVOLOCUMAB for Type iia hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5,556 adverse event reports in the FDA FAERS database where EVOLOCUMAB was used for Type iia hyperlipidaemia.
Most Reported Side Effects for EVOLOCUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device difficult to use | 31,807 | 21.3% | 11 | 538 |
| Drug dose omission by device | 23,957 | 16.0% | 7 | 327 |
| Wrong technique in product usage process | 21,664 | 14.5% | 4 | 285 |
| Accidental exposure to product | 16,160 | 10.8% | 3 | 154 |
| Injection site pain | 9,988 | 6.7% | 3 | 154 |
| Product storage error | 6,606 | 4.4% | 2 | 88 |
| Back pain | 5,254 | 3.5% | 14 | 201 |
| Myalgia | 5,061 | 3.4% | 15 | 177 |
| Drug dose omission | 4,914 | 3.3% | 1 | 87 |
| Injection site bruising | 4,409 | 3.0% | 1 | 83 |
| Device use error | 4,002 | 2.7% | 0 | 76 |
| Injection site haemorrhage | 3,720 | 2.5% | 1 | 50 |
| Arthralgia | 3,692 | 2.5% | 10 | 175 |
| Off label use | 3,558 | 2.4% | 23 | 153 |
| Fatigue | 3,506 | 2.3% | 7 | 165 |
Other Indications for EVOLOCUMAB
Product used for unknown indication (60,696)
Blood cholesterol increased (29,401)
Hypercholesterolaemia (23,505)
Blood cholesterol abnormal (13,116)
Hyperlipidaemia (10,208)
Low density lipoprotein increased (2,740)
Arteriosclerosis (2,094)
Type v hyperlipidaemia (1,816)
Coronary artery disease (1,266)
Dyslipidaemia (1,056)
Other Drugs Used for Type iia hyperlipidaemia
LOMITAPIDE (3,314)
ALIROCUMAB (1,913)
ATORVASTATIN (637)
EZETIMIBE (562)
ROSUVASTATIN (547)
INCLISIRAN (313)
SIMVASTATIN (294)
PRAVASTATIN (152)
JUXTAPID (145)
MIPOMERSEN (138)